Peter E. Fecci, MD, PhD, discusses therapeutic advances and challenges in the management of glioblastoma, and the trajectory of immunotherapy development.
Peter E. Fecci, MD, PhD
Advertisement
Peter E. Fecci, MD, PhD, is a professor and chair of the Department of Neurosurgery at the University of Colorado Anschutz
Articles by Peter E. Fecci, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
2
Dr Cerchione on the FDA Approval of Subcutaneous Isatuximab in Myeloma
3
Frontline Sac-TMT Plus Pembrolizumab Meets PFS End Point in PD-L1–Negative, Nonsquamous NSCLC
4
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer
5